4.7 Article

Arkadia-SKI/SnoN signaling differentially regulates TGF-β-induced iTreg and Th17 cell differentiation

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 218, 期 11, 页码 -

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20210777

关键词

-

资金

  1. Irvington Institute fellowship program of the Cancer Research Institute
  2. Helen and Martin Kimmel Center for Biology and Medicine
  3. Howard Hughes Medical Institute
  4. National Institutes of Health [2R01AI080885]

向作者/读者索取更多资源

TGF-beta signaling is crucial for differentiation of Th17 and Treg cells, with distinct requirements for downstream signaling components. Arkadia deficiency impairs Treg cell differentiation but is dispensable for Th17 cell responses. Genetic ablation of transcriptional corepressors SKI and SnoN rescues Arkadia-deficient iTreg cell differentiation.
TGF-beta signaling is fundamental for both Th17 and regulatory T (Treg) cell differentiation. However, these cells differ in requirements for downstream signaling components, such as SMAD effectors. To further characterize mechanisms that distinguish TGF-beta signaling requirements for Th17 and Treg cell differentiation, we investigated the role of Arkadia (RNF111), an E3 ubiquitin ligase that mediates TGF-beta signaling during development. Inactivation of Arkadia in CD4(+) T cells resulted in impaired Treg cell differentiation in vitro and loss of RORyt(+)FOXP3(+ )iTreg cells in the intestinal lamina propria, which increased susceptibility to microbiota-induced mucosal inflammation. In contrast, Arkadia was dispensable for Th17 cell responses. Furthermore, genetic ablation of two Arkadia substrates, the transcriptional corepressors SKI and SnoN, rescued Arkadia-deficient iTreg cell differentiation both in vitro and in vivo. These results reveal distinct TGF-beta signaling modules governing Th17 and iTreg cell differentiation programs that could be targeted to selectively modulate T cell functions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Meeting Abstract Gastroenterology & Hepatology

TUMOR NECROSIS FACTOR ALPHA (TNFα) CLEAVING ENZYME (TACE/ADAM17) EXPRESSION IS ENHANCED IN CHOLESTATIC LIVER DISEASE AND REGULATES CHOLESTASIS-ASSOCIATED LIVER INJURY AND SICKNESS BEHAVIOR DEVELOPMENT

Henry H. Nguyen, Charlotte D'Mello, Stefan Urbanski, Tyson S. Le, Wagdi Almishri, Mark G. Swain

GASTROENTEROLOGY (2017)

Editorial Material Gastroenterology & Hepatology

Not Your Ordinary Ulcer: A Cautionary Tale of an Uncommon Condition

Henry H. Nguyen, Paul L. Beck

GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunity

Henry H. Nguyen, Abdullah Khathlan, Marvin J. Fritzler, Mark G. Swain

BMC GASTROENTEROLOGY (2018)

Article Multidisciplinary Sciences

Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS)

Henry H. Nguyen, Abdel Aziz Shaheen, Natalia Baeza, Ellina Lytvyak, Stefan J. Urbanski, Andrew L. Mason, Gary L. Norman, Marvin J. Fritzler, Mark G. Swain

PLOS ONE (2018)

Article Gastroenterology & Hepatology

Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats

H. Nguyen, H. Wang, T. Le, W. Ho, K. A. Sharkey, M. G. Swain

NEUROGASTROENTEROLOGY AND MOTILITY (2008)

Article Gastroenterology & Hepatology

Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States

Abdel-Aziz Shaheen, Henry H. Nguyen, Stephen E. Congly, Gilaad G. Kaplan, Mark G. Swain

LIVER INTERNATIONAL (2019)

Article Biochemistry & Molecular Biology

Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease

June-Yong Lee, Jason A. Hall, Lina Kroehling, Lin Wu, Tariq Najar, Henry H. Nguyen, Woan-Yu Lin, Stephen T. Yeung, Hernandez Moura Silva, Dayi Li, Ashley Hine, P'ng Loke, David Hudesman, Jerome C. Martin, Ephraim Kenigsberg, Miriam Merad, Kamal M. Khanna, Dan R. Littman

Article Multidisciplinary Sciences

Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier

Jhimmy Talbot, Paul Hahn, Lina Kroehling, Henry Nguyen, Dayi Li, Dan R. Littman

NATURE (2020)

Article Immunology

ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice

Wagdi Almishri, Liam A. Swain, Charlotte D'Mello, Tyson S. Le, Stefan J. Urbanski, Henry H. Nguyen

Summary: Increased expression of ADAM17 is observed in cholestatic liver diseases. Inhibition of ADAM17 activity improves liver injury and associated sickness behavior development, suggesting that ADAM17 inhibition may be a potential therapeutic approach for patients with cholestatic liver diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Article Gastroenterology & Hepatology

Acute severe hepatitis as a presenting symptom in clinically stable patients admitted with SARS-CoV-2 Omicron infection

Liam A. Swain, Anshula Ambasta, Erika Prando Munhoz, Onyebuchi Omodon, Stefan J. Urbanski, Henry H. Nguyen

Summary: This study analyzed liver enzyme levels in patients with COVID-19 and conducted detailed case analyses of two patients. The findings suggest that the Omicron variant of SARS-CoV-2 may result in severe liver injury. Liver biopsy showed the presence of SARS-CoV-2 in the liver with immune cell infiltration. Therefore, the Omicron variant should be considered in the differential diagnosis of severe acute liver injury.

HEPATOLOGY COMMUNICATIONS (2023)

Review Neurosciences

Avenues within the gut-liver-brain axis linking chronic liver disease and symptoms

Henry H. Nguyen, Mark G. Swain

Summary: Symptoms of fatigue, social withdrawal and mood disturbances are common in patients with chronic liver disease. Limited treatment options exist for these symptoms, creating a medical need. This review examines potential mechanisms within the gut-liver-brain axis in chronic liver disease that contribute to the development of these symptoms, focusing on disruptions in immune response, microbiome, neural responses, and metabolite composition and their effects on the central nervous system.

FRONTIERS IN NEUROSCIENCE (2023)

Article Gastroenterology & Hepatology

Real-world tertiary referral centre experience stopping nucleos(t)ide analogue therapy in patients with chronic hepatitis B

Hassan Azhari, Alexandra D. Frolkis, Abdel Aziz Shaheen, Heidi Israelson, Jacqueline Pinto, Stephen E. Congly, Meredith A. Borman, Alexander A. Aspinall, Laura M. Stinton, Henry H. Nguyen, Mark G. Swain, Kelly W. Burak, Sam S. Lee, Matthew D. Sadler, Carla S. Coffin

Summary: Stopping nucleos(t)ide analogues (NUC) therapy is feasible in HBeAg negative chronic hepatitis B (CHB), but hepatic flares can still occur. Limited NUC therapy can be considered for eligible patients with close monitoring and follow-up in the first six months after stopping NUC therapy.

CANADIAN LIVER JOURNAL (2022)

Article Gastroenterology & Hepatology

Two-year retrospective analysis of patients undergoing direct to procedure flexible sigmoidoscopy investigation with rectal bleeding as a primary complaint

Henry H. Nguyen, Robert Bechara, William G. Paterson, Lawrence C. Hookey

ENDOSCOPY INTERNATIONAL OPEN (2018)

Article Gastroenterology & Hepatology

TNF-alpha-secreting monocytes are recruited into the brain of cholestatic mice

SM Kerfoot, C D'Mello, H Nguyen, MN Ajuebor, P Kubes, T Le, MG Swain

HEPATOLOGY (2006)

暂无数据